IGSF11 and neoplasm: VSIG3 is minimally expressed in normal tissues but is significantly upregulated in intestinal-type gastric cancer, colorectal cancer and hepatocellular carcinoma, indicating that the protein is important as a tumor-associated antigen (TAA) for clinical applications in tumor immunotherapy (10).